NVMI shares rise as second-quarter earnings and revenues beat estimates, with upbeat Q3 guidance fueling investor optimism.

Cardinal Health today reported fourth quarter fiscal year 2025 revenues of $60.2 billion, relatively flat compared to the ...

Reports Q2 revenue $5.6M vs. $6M last year. “We’re pleased to report another quarter of sequential growth, highlighting the continued momentum of our business as we execute on our long-term strategy,” ...

Gain insights into CEVA, Inc.'s Q2 2025 earnings call, showcasing AI momentum, licensing growth, IoT leadership, and a positive outlook on revenue ...

Ltd. Q2 results beat expectations with AI-led growth but faced a stock drop. This selloff is a long-term buying opportunity.

Please note that the limited information that follows in this press release is a summary and is not adequate for making an ...

Cash, cash equivalents, marketable securities and restricted cash as of June 30 totaled approximately $408.2M. Vlad Coric, Chairman and CEO of ...

GAAP revenue for Q2 2025 was $161.1 million, falling short of analyst estimates of $164.5 million. Adjusted diluted EPS (non-GAAP) for Q2 2025 was $0.51, slightly above the consensus estimate of $0.50 ...

Key Points GAAP revenue of $20.5 million in Q2 2025 surpassed analyst expectations by 9.3%, despite a decline from the same period in 2024. Non-GAAP loss per share was $(0.01) in Q2 2025. Cash ...

Fourth quarter revenue was relatively flat at $60.2 billion; revenue increased 21% excluding the impact of a previously communicated contract expiration Fourth quarter ...